Title: Impacts on Life Quality and Immune Function in the Patients of Non-Small Cell Lung Cancer at the Late Stage Treated with Shenqi Xiebai Powder Combined with Chemotherapy
Abstract: Objective To observe the impacts on life quality and immune function of the patients of non- small cell lung cancer at the late stage( NSCLC) treated with Shenqi Xiebai Powder combined with chemotherapy. Methods Seventy- two patients were divided into a treatment group( 37 cases) and a control group( 35 cases) according to random number table. In the control group,TP program of chemotherapy was adopted. In the treatment group,on the basic treatment as the control group,2 days before chemotherapy,Shenqi Xiebai Powder was supplemented. The treatment of 28 days was 1 period and 2 periods were required continuously. The symptom score of Chinese medicine,the score of life quality,KPS score,immune function and adverse reactions were observed before and after treatment in the patients of two groups. Results The symptom score of Chinese medicine,the score of life quality and KPS score were all improved after treatment in the treatment group,indicating the significant differences as compared with those before treatment in the same group and those after treatment in the control( P 0. 05). After two periods of chemotherapy,CD4+and CD4+/ CD8+levels were reduced apparently as compared with those before treatment in the control group( P 0. 05); the levels of CD3+,CD4+,CD8+and CD4+/ CD8+were all increased as compared with those before treatment in the treatment group( P 0. 05). In comparison of the two groups,the levels of CD4+and CD4+/ CD8+in the treatment group were higher than those in the control group after treatment( P 0. 05). The incidence of the adverse reactions in the treatment group was lower than that in the control group( P 0. 05). Conclusion The combined therapy of Shenqi Xiebai Powder and chemotherapy improves body immune function,relieves clinical symptoms,reduces adverse reactions,enhances life quality and prolongs life span in the patients of NSCLC at the late stage.
Publication Year: 2014
Publication Date: 2014-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot